SMTL ID : 6v7f.1 (1 other biounit)

Human Arginase1 Complexed with Bicyclic Inhibitor Compound 13

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.02 Å

Oligo State

homo-trimer

Ligands

6 x MN: MANGANESE (II) ION(Non-covalent)

MN.1: 6 residues within 4Å: Chain A: H.101, D.124, D.128, D.232 Ligands: MN.2, QRJ.3 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.101, A:D.124, A:D.128, A:D.232 MN.2: 6 residues within 4Å: Chain A: D.124, H.126, D.232, D.234 Ligands: MN.1, QRJ.3 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Ligand interactions Metal complexes: A:D.124, A:H.126, A:D.232, A:D.234, QRJ.3 MN.4: 6 residues within 4Å: Chain B: H.101, D.124, D.128, D.232 Ligands: MN.5, QRJ.6 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:H.101, B:D.124, B:D.128, B:D.232 MN.5: 6 residues within 4Å: Chain B: D.124, H.126, D.232, D.234 Ligands: MN.4, QRJ.6 5 PLIP interactions: 4 interactions with chain B, 1 Ligand-Ligand interactions Metal complexes: B:D.124, B:H.126, B:D.232, B:D.234, QRJ.6 MN.7: 6 residues within 4Å: Chain C: H.101, D.124, D.128, D.232 Ligands: MN.8, QRJ.9 4 PLIP interactions: 4 interactions with chain C Metal complexes: C:H.101, C:D.124, C:D.128, C:D.232 MN.8: 7 residues within 4Å: Chain C: D.124, H.126, D.232, D.234, T.246 Ligands: MN.7, QRJ.9 5 PLIP interactions: 4 interactions with chain C, 1 Ligand-Ligand interactions Metal complexes: C:D.124, C:H.126, C:D.232, C:D.234, QRJ.9

3 x QRJ: {3-[(5R,7S,8S)-8-azaniumyl-8-carboxy-2-azaspiro[4.4]nonan-2-ium-7-yl]propyl}(trihydroxy)borate(1-)(Non-covalent)

QRJ.3: 17 residues within 4Å: Chain A: H.101, D.124, H.126, D.128, N.130, S.137, H.141, G.142, D.181, D.183, E.186, D.232, D.234, T.246, E.277 Ligands: MN.1, MN.2 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:H.126, A:T.246 Hydrogen bonds: A:N.130, A:S.137, A:D.181, A:D.183, A:T.246, A:T.246 Water bridges: A:S.137, A:S.137, A:N.139, A:N.139, A:D.183, A:T.246, A:T.246 QRJ.6: 17 residues within 4Å: Chain B: H.101, D.124, H.126, D.128, N.130, S.137, H.141, G.142, D.181, D.183, E.186, D.232, D.234, T.246, E.277 Ligands: MN.4, MN.5 15 PLIP interactions: 15 interactions with chain B Hydrophobic interactions: B:H.126, B:T.246 Hydrogen bonds: B:N.130, B:S.137, B:D.183, B:T.246, B:E.277 Water bridges: B:D.128, B:T.135, B:S.137, B:S.137, B:G.142, B:D.181, B:D.181, B:T.246 QRJ.9: 17 residues within 4Å: Chain C: H.101, D.124, H.126, D.128, N.130, S.137, H.141, G.142, D.181, D.183, E.186, D.232, D.234, T.246, E.277 Ligands: MN.7, MN.8 13 PLIP interactions: 13 interactions with chain C Hydrophobic interactions: C:T.246 Hydrogen bonds: C:N.130, C:S.137, C:D.181, C:D.183, C:T.246, C:T.246 Water bridges: C:D.128, C:T.135, C:S.137, C:N.139, C:H.141, C:D.183

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mitcheltree, M.J. et al., Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy. Acs Med.Chem.Lett. (2020)

Release Date

2020-05-06

Peptides

Arginase-1: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
E

Arginase-1

Related Entries With Identical Sequence